TAK-981 induced an overexpression of CD69, a marker of lymphocytes activation, on the surface of purified NK cells treated for 24 h and co-cultured for 4 h with U937 AML cell line as target cells (Figure 1C). The gene discussed is CD69; the disease is acute myeloid leukemia.